Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Commodities›Chemicals›Chemicals & Petrochemicals

LINK PHARMA CHEM LTD.

Chemicals › Chemicals & Petrochemicals
₹25.60
at close · 28 Oct 2026
▼ 0.40 (-1.54%)

Latest filings

Next results: Tue, 3 Nov · Financial Results
  1. Board meeting scheduled for November 3, 2026 results · Results
  2. GST demand cut from Rs 1.33 cr to Rs 16.3 lakh by Tribunal · Regulatory & Legal
  3. Routine quarterly RTA confirmation certificate filed with BSE · Compliance
All filings ↓
Ask Nexa about LINK PHARMA CHEM LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

A Chemicals & Petrochemicals company listed on BSE, reporting revenue of ₹28 Cr over the trailing twelve months.

Market Cap
₹11 Cr
P / E (TTM)
—
EV / EBITDA
11.3×
Div Yield
—
Growth
-4.7%▼
Revenue 5y CAGR
PAT -41.1% · EBITDA -11.3%
Quality
4.8%·
ROCE (5y median)
ROE 0.6% (5y median) · margin 6.0%
Leverage
0.57·
Debt / Equity · moderate
Net debt ₹6.76 Cr
Revenue FY21→FY26
0.8×▼
Margin −2.8 pts
₹35 Cr → ₹27 Cr
Cash conversion
8.30×▲
Operating cash ÷ profit · 5 yrs
₹2 Cr on ₹0 Cr
Moves on a normal day
2.73%·
Median daily move
Last 254 sessions · the yardstick for filing-day moves
Where it sits among 66 Commodity Chemicals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/B#19/60
ROCE#45/62
ROE#44/60
Debt / Equity#42/60
EBITDA margin#36/58
Revenue growth#22/54
Profit growth#44/64

Scorecard

Measured from the filed financials, judged against its Commodity Chemicals peers · as of FY26 — not investment advice

Strengths
Over 5 years it reported ₹0.22 Cr of profit and ₹1.85 Cr of operating cash — 8.30×
Profit is converting into cash
Concerns
Revenue shrinking over 5 years (−5% a year)
Profit shrinking over 5 years (−41% a year)
Returns on capital 4.8% (5-year median)
#45 of 62 in Commodity Chemicals on the latest reported figures · down from 12.6% in FY21

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from LINK PHARMA CHEM LTD.'s filed financials and exchange disclosures

What does LINK PHARMA CHEM LTD. do?

LINK PHARMA CHEM LTD. is a Chemicals & Petrochemicals company listed on BSE.

Is LINK PHARMA CHEM LTD. profitable?

No. Over the trailing twelve months LINK PHARMA CHEM LTD. reported a net loss of ₹0.01 Cr on revenue of ₹28 Cr.

Does LINK PHARMA CHEM LTD. pay a dividend?

Not in the latest reported year — LINK PHARMA CHEM LTD.'s dividend payout for FY26 was nil.

Is LINK PHARMA CHEM LTD. debt-free?

No. It reported borrowings of ₹7.30 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹6.76 Cr after cash. Debt stands at 0.57× equity. That is higher than 69% of its 60 Commodity Chemicals peers.

How much does the LINK PHARMA CHEM LTD. share price move in a day?

On a typical session LINK PHARMA CHEM LTD. moves 2.73% — that is the median absolute close-to-close move across its last 254 trading days. MarketPing measures each filing's price reaction against it.

When are LINK PHARMA CHEM LTD.'s next results?

Financial Results on Tue, 3 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track LINK PHARMA CHEM LTD.'s announcements?

Every NSE and BSE filing by LINK PHARMA CHEM LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.